Atlas Trials

Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant

Clinical trial NCT00241345 · TERMINATED

Trial details

NCT number
NCT00241345
Sponsor
Washington University School of Medicine
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Cytomegalovirus Infections
Start date
2004-06-01
Primary completion
2007-11-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.